1. Home
  2. MMS vs ACLX Comparison

MMS vs ACLX Comparison

Compare MMS & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MMS
  • ACLX
  • Stock Information
  • Founded
  • MMS 1975
  • ACLX 2015
  • Country
  • MMS United States
  • ACLX United States
  • Employees
  • MMS N/A
  • ACLX N/A
  • Industry
  • MMS Business Services
  • ACLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MMS Consumer Discretionary
  • ACLX Health Care
  • Exchange
  • MMS Nasdaq
  • ACLX Nasdaq
  • Market Cap
  • MMS 4.3B
  • ACLX 3.8B
  • IPO Year
  • MMS 1997
  • ACLX 2022
  • Fundamental
  • Price
  • MMS $80.46
  • ACLX $73.06
  • Analyst Decision
  • MMS Buy
  • ACLX Strong Buy
  • Analyst Count
  • MMS 1
  • ACLX 14
  • Target Price
  • MMS $90.00
  • ACLX $114.75
  • AVG Volume (30 Days)
  • MMS 502.7K
  • ACLX 436.7K
  • Earning Date
  • MMS 08-07-2025
  • ACLX 08-19-2025
  • Dividend Yield
  • MMS 1.51%
  • ACLX N/A
  • EPS Growth
  • MMS 12.65
  • ACLX N/A
  • EPS
  • MMS 5.37
  • ACLX N/A
  • Revenue
  • MMS $5,428,731,000.00
  • ACLX $76,809,000.00
  • Revenue This Year
  • MMS $2.13
  • ACLX N/A
  • Revenue Next Year
  • MMS $3.36
  • ACLX $108.81
  • P/E Ratio
  • MMS $14.76
  • ACLX N/A
  • Revenue Growth
  • MMS 3.40
  • ACLX N/A
  • 52 Week Low
  • MMS $63.77
  • ACLX $47.86
  • 52 Week High
  • MMS $93.94
  • ACLX $107.37
  • Technical
  • Relative Strength Index (RSI)
  • MMS 65.98
  • ACLX 59.96
  • Support Level
  • MMS $70.34
  • ACLX $70.13
  • Resistance Level
  • MMS $82.90
  • ACLX $72.98
  • Average True Range (ATR)
  • MMS 2.08
  • ACLX 2.63
  • MACD
  • MMS 0.57
  • ACLX -0.07
  • Stochastic Oscillator
  • MMS 61.07
  • ACLX 70.86

About MMS Maximus Inc.

Maximus Inc designs, develops, and delivers programs, enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments; U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.

About ACLX Arcellx Inc.

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

Share on Social Networks: